Clinical Guides
Deworming Programme
A clinically focused clinical and programme guide to India's National Deworming Day, explaining preventive chemotherapy, individual assessment, age and pregnancy limits, observed albendazole administration, adverse-event readiness, coverage measurement and the role of water, sanitation and hygiene.
MedNext Academy | 13 min read
Deworming Programme
A clinically focused clinical and programme guide to India's National Deworming Day, explaining preventive chemotherapy, individual assessment, age and pregnancy limits, observed albendazole administration, adverse-event readiness, coverage measurement and the role of water, sanitation and hygiene.
Summary
A deworming programme uses periodic preventive chemotherapy to reduce the population burden of soil-transmitted helminths where epidemiology justifies mass treatment. India's National Deworming Day uses schools and Anganwadi centres to reach children and adolescents, including deliberate mobilisation of those not enrolled in school and a mop-up opportunity for eligible people missed on the main day. The programme is not a diagnosis of infection in every recipient and a recorded tablet distribution is not proof that the medicine was swallowed.
The principal soil-transmitted helminths are Ascaris lumbricoides, Trichuris trichiura and hookworms. They can impair nutrition through blood loss, inflammation, reduced intake and nutrient absorption; heavy infection can cause substantial morbidity. Preventive albendazole lowers worm burden but does not create lasting immunity. Reinfection continues when unsafe sanitation, contaminated soil, inadequate hand hygiene and barefoot exposure persist, so water, sanitation, hygiene, footwear and health education are essential complementary measures.
Programme dosing must remain age- and formulation-specific. The Indian operational guideline describes 200 mg for children aged 1 to under 2 years and 400 mg for ages 2-19 years, with tablet preparation and observed administration adapted to age. Do not extrapolate this campaign schedule to infants under one year, pregnancy, symptomatic disease or non-target adults. Severe illness, possible obstruction, acute abdomen or a significant adverse event requires clinical assessment, not another campaign dose. This draft is educational, has been reviewed by the MedNext Clinical Team and reviewed.
How Common Is It?
Soil-transmitted helminth transmission varies sharply with sanitation, climate, poverty, behaviour and prior treatment. National Deworming Day is a broad public-health platform, but participation in the programme does not prove that a child is infected. Conversely, absence of worms in one stool sample does not exclude light or intermittent infection. WHO bases preventive-chemotherapy frequency on endemicity and baseline prevalence in defined at-risk populations, not on a universal timetable detached from surveillance. Annual treatment is used at a lower programme threshold and biannual treatment at higher prevalence in WHO recommendations; national policy may operationalise these principles through its own mapping and schedule.
Programme managers need separate measures for target population, enrolled and out-of-school populations, tablets supplied, people reached, doses actually administered, refusals, illness-related exclusions, absences and mop-up doses. Using school enrolment alone undercounts non-enrolled or mobile children. Using tablets issued as the numerator inflates effective coverage when tablets are lost, refused or not swallowed. Age-disaggregated and sex-disaggregated reporting helps detect inequity.
Burden estimates from an old survey or another district should not be converted into an individual probability. Intensity of infection matters clinically because morbidity is concentrated in heavier infections. Hookworm contributes to chronic blood loss and anaemia, while Ascaris can obstruct the intestine in heavy infection. Monitoring should therefore consider epidemiological infection indicators, coverage quality, adverse events and complementary sanitation rather than celebrate a large number of distributed tablets as the only outcome.
Risk Factors
Risk is greatest where human faeces contaminate soil and people lack safe sanitation, clean water and consistent handwashing. Children who play on contaminated ground, eat without washing hands, practise geophagia or have inadequate nail hygiene may ingest infective Ascaris or Trichuris eggs. Hookworm larvae penetrate skin, making barefoot exposure important. Crowding, open defecation, unsafe disposal of child faeces, seasonal migration, remote residence and interrupted school attendance can increase exposure or reduce programme reach. Reinfection after successful treatment is common if these conditions persist.
Individual morbidity is influenced by species and worm burden as well as age, diet, baseline iron status and pregnancy. Hookworm-related blood loss can worsen iron deficiency; poor appetite and intestinal effects can compound undernutrition. Children with pica, recurrent abdominal symptoms, growth concerns or anaemia need clinical thinking rather than being assumed to have worms. Previous deworming does not exclude reinfection, while an undocumented community campaign does not confirm the exact drug or dose received.
Programme risk includes wrong age classification, unreliable denominators, inadequate training, unobserved administration, medicine stock imbalance, expired or damaged tablets, and failure to include out-of-school children. Giving a tablet to a very young child without crushing or safe supervision creates aspiration risk. Treating an acutely unwell child in a crowd may obscure a non-helminth illness. Pregnancy possibility matters outside the 1-19-year target and in older adolescents. Document allergy or prior serious reaction and distinguish risk communication from exaggerated claims that albendazole is free of all adverse effects.
Diagnosis
History
For programme eligibility, verify age, whether a dose was already received in the current round, current illness, swallowing ability and relevant local exclusions. Ask the caregiver or adolescent rather than relying only on a class register. For a symptomatic individual, establish pain, distension, vomiting, stool change, visible worms, pruritus, cough, fever, appetite, weight or growth trajectory, pica, pallor, blood loss, travel, sanitation, footwear, prior antiparasitic treatment and pregnancy possibility. A campaign encounter should not turn every nonspecific symptom into helminthiasis.
Examination
Before administration, identify a child who appears acutely unwell, is vomiting, has altered consciousness, respiratory compromise or cannot safely chew or swallow. In clinical assessment record hydration, growth or nutritional status, pallor, abdominal distension, tenderness, guarding, masses, organ enlargement and signs of obstruction. Examine skin and lungs when the history suggests alternative disease. Severe pallor, oedema, fever or focal abdominal signs require facility assessment. Absence of a visible sign neither confirms nor excludes a light infection.
Investigations
Mass preventive chemotherapy does not require stool testing of every eligible recipient. Surveillance uses standardised sampling and validated parasitological methods to estimate prevalence and intensity. In an individual with persistent symptoms, diagnostic uncertainty or treatment failure, stool microscopy or other locally available tests may be selected; multiple specimens or concentration methods can improve sensitivity. A full blood count and iron studies may be needed for anaemia, but eosinophilia is nonspecific and may be absent. Laboratories must report method, units and specimen quality. Do not delay urgent imaging or surgical referral when obstruction, perforation or another acute abdomen is possible.
Differential Diagnosis
Abdominal pain, poor appetite and growth concerns are common and cannot be attributed to worms solely because the child lives in an endemic area. Differential diagnoses include constipation, gastroenteritis, urinary infection, appendicitis, coeliac disease, inflammatory bowel disease, tuberculosis, food intolerance, functional abdominal pain and food insecurity. Bilious vomiting, marked distension, obstipation or peritonism raises obstruction or perforation and requires urgent assessment; heavy Ascaris may be one cause, but a programme tablet is not acute management.
Anaemia may result from iron deficiency due to diet or blood loss, malaria, haemoglobinopathy, chronic inflammation, kidney disease, vitamin B12 or folate deficiency and marrow disorders. Hookworm can contribute, but haemoglobin does not identify the cause. Eosinophilia also occurs with allergy, medicines and other parasites. Perianal itching suggests Enterobius, which has different household and treatment considerations and is not the main target of soil-transmitted-helminth prevalence programmes. Strongyloides requires specific diagnostic and treatment pathways, especially before immunosuppression; a single campaign dose of albendazole is not reliable definitive therapy.
Visible segments or a seizure with possible neurocysticercosis raises cestode disease, not routine NDD management. Schistosomiasis depends on freshwater exposure in endemic regions and requires species-appropriate testing and praziquantel rather than albendazole. Weight loss, prolonged fever, blood in stool, jaundice or organ enlargement should reopen the diagnosis. In a population report, low coverage can reflect denominator failure, migration or recording error rather than reluctance; apparent high coverage may reflect tablets distributed rather than swallowed.
Management
Programme management begins with a validated target denominator, intersectoral coordination and medicine forecasting. Health, education and women-and-child-development teams need aligned microplans for schools, Anganwadi centres and out-of-school children. Train administrators to verify age and previous dosing, observe swallowing, prepare tablets safely for younger children, record actual administration, recognise adverse events and activate referral. Community messages should explain both benefit and limits without claiming that one dose permanently prevents infection. A mop-up day is for eligible people missed because of absence or temporary illness, not automatic repeat dosing.
The Indian guideline uses a single age-specific albendazole dose within NDD: 200 mg for children aged 1 to under 2 years and 400 mg for ages 2-19 years. The exact current national or state protocol, product strength and round dates must be checked before implementation. The tablet should be administered under supervision with age-appropriate crushing or chewing instructions and clean water as specified locally. Infants under one year are outside this schedule. Do not improvise doses for pregnancy or non-target adults from a school campaign table.
Mild transient abdominal discomfort, nausea, vomiting, dizziness or headache may occur, sometimes more noticeably with heavy worm burden. Keep children under observation as required, provide calm assessment and follow the official adverse-event algorithm. Serious symptoms need facility care and pharmacovigilance reporting. At individual level, persistent disease, another parasite or complication requires diagnosis-specific therapy. At population level, repeat chemotherapy must be combined with sanitation, safe water, handwashing, footwear, food hygiene and surveillance to reduce reinfection and track whether the strategy remains appropriate.
Prescribing Information
For National Deworming Day, prescribe or administer only the product and dose in the current operational protocol. Verify albendazole tablet strength, batch, expiry and storage. The operational age split is 200 mg as half of a 400 mg tablet for 1 to under 2 years and 400 mg for 2-19 years. Younger children require the specified crushing and supervised administration approach to reduce choking risk. Never ask a child to take the tablet home as a recorded observed dose, and never count a tablet handed out but not swallowed as treatment.
This is preventive chemotherapy, not a universal prescription for every helminth species. Individual regimens vary by organism, clinical syndrome, age, weight, pregnancy, liver status and product label. Strongyloidiasis generally needs ivermectin-based management, while schistosomiasis needs praziquantel; suspected neurocysticercosis must not be treated casually because antiparasitic therapy can provoke inflammation. Intestinal obstruction or acute surgical disease is not managed by mass albendazole. Repeated dosing after vomiting should follow the verified protocol rather than guesswork.
Pregnancy requires a separate pathway. WHO supports preventive deworming after the first trimester in specified endemic settings, and India's maternal-health or AMB protocols should be checked for current practice. Do not expose a possible first-trimester pregnancy to a campaign dose without policy and clinical verification. Record allergy, prior reaction and medicines. Explain that mild gastrointestinal symptoms can occur and give explicit escalation instructions. Programme staff administer within authorisation; complex clinical prescribing belongs to a qualified clinician with diagnosis, consent and follow-up.
When to Refer
Send an eligible but temporarily unwell child to the designated mop-up pathway only when the illness has resolved and the current protocol allows it. Refer for clinical assessment rather than campaign dosing when there is persistent vomiting, severe abdominal pain, marked distension, inability to pass stool or gas, gastrointestinal bleeding, severe pallor, oedema, significant weight loss, prolonged fever, respiratory distress, altered consciousness or inability to swallow safely. Suspected obstruction, perforation, severe anaemia or another acute abdomen needs urgent facility care.
Refer non-urgently but deliberately for recurrent symptoms after appropriate treatment, repeated visible worms, unexplained eosinophilia, growth faltering, iron deficiency that does not respond as expected, suspected malabsorption or an epidemiological exposure suggesting Strongyloides, schistosomiasis or another non-programme parasite. People about to receive substantial corticosteroid or other immunosuppression with Strongyloides exposure need risk-based specialist assessment because hyperinfection can be life-threatening. Pregnancy, infancy under one year, chronic liver disease and previous serious medicine reaction require a separate clinical or protocol decision.
Programme referral pathways should name the nearest facility, transport plan, responsible contact and adverse-event reporting route before dosing starts. A severe event must be stabilised and reported without implying causality before assessment. Programmes should also escalate operational failures: unexpected clusters of illness, wrong-dose administration, compromised stock, aspiration, very low coverage, exclusion of out-of-school groups or inconsistent denominators. Referral documentation should include dose, strength, batch where available, time, symptoms, observations and actions taken.
Red Flags
Before dosing, red flags include altered consciousness, active convulsion, repeated vomiting, respiratory difficulty, inability to swallow, severe dehydration, shock, a rigid or markedly distended abdomen, bilious vomiting, gastrointestinal bleeding or suspected intestinal obstruction. Do not force oral medicine. Stabilise within competence and arrange urgent transfer. A child with fever or mild intercurrent illness requires the current programme exclusion and mop-up guidance; staff should not invent a threshold or hide an illness to improve coverage.
After albendazole, emergency features include collapse, breathing difficulty, facial or tongue swelling, widespread urticaria with systemic symptoms, persistent vomiting with dehydration, severe or worsening abdominal pain, altered consciousness or seizure. Mild nausea or transient discomfort may occur, but labelling every post-dose illness a harmless drug effect risks missing appendicitis, infection or another acute condition. Conversely, serious events require transparent assessment and reporting without premature causal claims. Record the timeline and batch information.
Outside a campaign, worms with obstructive symptoms, severe anaemia, haemodynamic compromise, rapidly progressive malnutrition, focal neurological signs or possible neurocysticercosis needs specialist care. Pregnancy in the first trimester is a prescribing boundary, not a minor registration detail. Infants under one year fall outside the NDD age schedule. Operational red flags include coercive administration, untrained staff, absent clean water or emergency contacts, expired stock, duplicate dosing, falsified coverage, and no route for non-enrolled children. Pausing an unsafe session is better programme practice than achieving an unreliable target.
Indian Clinical Context
National Deworming Day is led by the Ministry of Health and Family Welfare with education and women-and-child-development partners. Schools provide reach for enrolled children, while Anganwadi centres and ASHA-supported mobilisation are crucial for preschool and out-of-school children and adolescents. The official operational guideline describes a fixed-day campaign with a mop-up opportunity, training, drug logistics, community mobilisation, monitoring and an adverse-event system. State implementation details and dates must be verified for the current round; a historical PDF should not be treated as proof that every operational detail is unchanged.
Anemia Mukt Bharat places periodic deworming within a wider life-course strategy that also includes iron-folic acid supplementation, behaviour change, haemoglobin testing and treatment, fortified foods and attention to non-nutritional causes. Deworming can reduce one contributor to anaemia but cannot establish that anaemia is due to hookworm or replace iron-status evaluation. For pregnant women, care is delivered through antenatal pathways and the applicable maternal-health protocol, not a school-dose extrapolation.
Quality depends on denominator integrity. Reconcile school enrolment, Anganwadi registers and local mapping without double counting; identify migrant, tribal, remote, disabled and non-enrolled beneficiaries. Report doses administered, not stock dispatched. Audit age split, observed swallowing, absences, exclusions, mop-up, adverse events and referral completion. Pair the campaign with safe sanitation, handwashing, footwear and behaviour change. These measures address reinfection and equity, whereas repeated tablets alone cannot interrupt environmental transmission.
NMC Competency Mapping
This guide maps to Community Medicine competencies on the epidemiology and control of soil-transmitted helminth infection, school health, nutrition, environmental sanitation, national health programmes, surveillance, programme planning and evaluation. A learner should explain the transmission cycle of Ascaris, Trichuris and hookworms; distinguish individual case management from population preventive chemotherapy; and relate worm burden to anaemia and undernutrition without asserting that every anaemic child has helminthiasis. Exact competency identifiers should be reconciled against the institution's current NMC CBME ledger.
Practical competence includes verifying an age-specific programme dose, preparing and supervising oral administration safely, documenting actual ingestion, communicating expected minor symptoms, recognising an adverse event and activating referral. Students should be able to construct a defensible denominator, distinguish enrolled from out-of-school reach, explain mop-up logic and calculate coverage using administered doses rather than tablets distributed. They should identify how selection bias, migration, duplication and missing registers distort evaluation.
A complete answer also covers primary prevention: sanitation, safe disposal of faeces, hand hygiene, footwear, food hygiene and health education. Learners must know the boundaries for infancy, pregnancy, acute illness, obstruction, other helminth species and immunosuppression. Reading or observing a campaign does not certify unsupervised prescribing or adverse-event management. Assessment should reward safety, epidemiological reasoning and honest programme evaluation rather than memorisation of one date in isolation.
Key Exam Pearls for NEET PG
Soil-transmitted helminths are Ascaris lumbricoides, Trichuris trichiura and the hookworms Ancylostoma duodenale and Necator americanus. Ascaris and Trichuris eggs are ingested; hookworm larvae penetrate skin. Heavy Ascaris infection may cause intestinal obstruction. Hookworm produces chronic intestinal blood loss and can contribute to iron-deficiency anaemia. Preventive chemotherapy reduces worm burden but reinfection occurs when sanitation and hygiene remain poor. Mass administration is based on population risk and does not require stool microscopy for every recipient.
For India's NDD operational schedule, remember the age boundary: 1 to under 2 years receives 200 mg albendazole, while 2-19 years receives 400 mg, with supervised age-appropriate preparation. Infants under one year are not included. Verify the current official protocol rather than assuming that dates and implementation details never change. A mop-up day reaches eligible people missed on the main day; it is not a second routine dose. Doses swallowed, not tablets supplied, form the meaningful coverage numerator.
Do not confuse parasites or programmes. A single albendazole campaign dose is not definitive Strongyloides management, praziquantel is used for schistosomiasis, and suspected neurocysticercosis requires specialist evaluation. Pregnancy requires trimester- and policy-specific assessment. Eosinophilia is neither sensitive nor specific. Severe pain, distension, bilious vomiting, obstipation, collapse or allergic features demand referral. The complete public-health answer is preventive chemotherapy plus water, sanitation, hygiene, footwear, inclusion of out-of-school children, adverse-event readiness and surveillance.
Frequently Asked Questions
Does every child need a stool test before National Deworming Day medicine?
No. Preventive chemotherapy is a population intervention used where epidemiology and policy justify treatment, so routine stool testing of every eligible child is not required. That does not mean every recipient is infected. A child with persistent symptoms, treatment failure, severe illness or suspected non-programme parasite may need individual examination and targeted laboratory testing rather than repeated campaign dosing.
What albendazole dose is used in the Indian child and adolescent campaign?
The national operational guideline describes 200 mg for children aged 1 to under 2 years and 400 mg for ages 2-19 years, with supervised, age-appropriate crushing or chewing. Infants under one year are outside this schedule. Teams must verify the current state and national protocol, formulation and round instructions before use; this campaign dose is not a universal treatment regimen.
Can albendazole be given during pregnancy as part of a school campaign?
Pregnancy needs a separate clinical and programme pathway. WHO guidance supports preventive deworming after the first trimester in defined endemic settings, while Indian maternal-health and AMB protocols determine local delivery. A school schedule should not be extrapolated to pregnancy, and possible first-trimester pregnancy must be identified before prescribing. Verify eligibility, indication, gestation and current official guidance.
How should deworming programme coverage be calculated and interpreted?
Use the eligible target population as the denominator and doses actually administered as the numerator, with clear age, sex, school-enrolment and geography breakdowns. Report main-day and mop-up doses without duplication, and retain refusals, absences, illness exclusions and missing data. Tablets supplied or handed out are not equivalent to swallowed doses, while high coverage alone does not prove lower infection intensity or better nutrition.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic